• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

14
2
1
1
1

COUNTRY

1
1
1

CATEGORIES

  • 48
  • 21
  • 9
  • 7
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

8
9
12
105

PUBLISHED

0
5
53
105

PRODUCT TYPE

96
9

Search "Merck KGaA-Therapeutic Competitors Report" returned 105 results.

PRODUCT TITLE

IMS Company Profiles:Merck KGaA

IMS Company Profiles gives a clear picture of the companies' strengths in terms of therapy areas and relevant marketed products as well as the future strategic direction of companies including R&D pipelines,...

October 2013

Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Non-Small Cell...

November 2011
FROM

Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Multiple Sclerosis Therapeutics...

February 2012
FROM
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

March 2014
FROM

Global Flow Cytometry Market

Flow cytometry is a laboratory analytical technique that can rapidly measure multiple parameters of individual cells or particles as they pass through a beam of light, typically a laser The global flow...

May 2014
FROM

Gastric Cancer - Germany Drug Forecasts and Treatment Analysis to 2020

Gastric Cancer - Germany Drug Forecasts and Treatment Analysis to 2020 Summary Global Data, the industry analysis specialist, has released its new report, “Gastric Cancer - Germany Drug Forecasts...

April 2011
FROM
Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing breast cancer drug development Find out whether you are number one, two or further down the ladder...

August 2012
FROM
Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing pancreatic cancer drug development Find out whether you are number one, two or further down the ladder...

March 2012
FROM
A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 282 lymphoma drugs within the portfolio of 152 companies, from Ceased to Marketed The report extensively analyses their 181 identified...

May 2011
FROM
Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market - Product Thumbnail Image

Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market

This report comprises defined and up to date development strategies for 416 lung cancer drugs within the portfolio of 217 companies, from Ceased to Marketed The report extensively analyses their 241...

July 2011
FROM
Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing angiogenesis affecting drug development in cancer Find out whether you are number one, two or further...

January 2012
Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others

This report represents a new and unique way of stratifying and analyzing the global protein kinase drug pipeline in oncology towards personalized medicine It will excel your competitive awareness and...

May 2012
FROM
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 companies, from Ceased to Marketed The report extensively analyses their...

March 2011
FROM

Brazil Pharmaceuticals and Healthcare Report Q2 2011

Business Monitor International's Brazil Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

March 2011

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 Summary This, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the...

February 2015
FROM

Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

What Will the Pharma Industry Look Like in 5 Years? There are an estimated 724 projects in development from the top 50 pharmaceutical companies.  Together, they have the potential to add billions...

August 2012
FROM

Rectal Cancer - Pipeline Review, H1 2014

Rectal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H1 2014’, provides an overview of the Rectal Cancer’s therapeutic pipeline. This report...

February 2014
FROM
Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016 Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016 - Product Thumbnail Image

Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016

Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016 Summary “Polycystic Ovarian Syndrome- Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source...

April 2010
FROM

Cartilage Degeneration - Pipeline Review, H1 2014

Cartilage Degeneration - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cartilage Degeneration - Pipeline Review, H1 2014’, provides an overview of the Cartilage Degeneration’s therapeutic...

May 2014
FROM

Indolent Lymphoma - Pipeline Review, H1 2014

Indolent Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This...

April 2014
FROM
Loading Indicator

Our Clients

Ikea Systems B.V. GlaxoSmithKline PLC BT Group PLC. Philips N.V. BSH Home Appliances Ltd Foreign & Commonwealth Office